Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
CFO resigned
CC transcript
Appointed director
|
|
OSIRIS THERAPEUTICS, INC. (OSIR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/29/2019 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 04/17/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/17/2019 |
4
| FRIEDLI PETER (Director) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Disposed/sold 10,204,404 shares
@ $19, valued at
$193.9M
Disposed/sold 4,103,301 shares
@ $19, valued at
$78M
Disposed/sold 500,000 shares
@ $19, valued at
$9.5M
Disposed/sold 2,750 shares
@ $19, valued at
$52.3k
|
|
| 04/17/2019 |
4
| Keefer Jason (Chief Commercial Officer) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Disposed/sold 4,000 shares
@ $19, valued at
$76k
Disposed/sold 16,000 options to buy
@ $6.8, valued at
$108.8k
Disposed/sold 20,000 options to buy
@ $10.53, valued at
$210.6k
|
|
| 04/17/2019 |
4
| Danilkovitch Alla (Chief Scientific Officer) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Disposed/sold 9,375 shares
@ $19, valued at
$178.1k
Disposed/sold 8,000 options to buy
@ $7.74, valued at
$61.9k
Disposed/sold 5,000 options to buy
@ $6.46, valued at
$32.3k
Disposed/sold 9,000 options to buy
@ $7.13, valued at
$64.2k
Disposed/sold 6,000 options to buy
@ $5.08, valued at
$30.5k
Disposed/sold 10,000 options to buy
@ $7.73, valued at
$77.3k
Disposed/sold 1,436 options to buy
@ $14, valued at
$20.1k
Disposed/sold 18,564 options to buy
@ $14, valued at
$259.9k
Disposed/sold 7,644 options to buy
@ $18.4, valued at
$140.6k
Disposed/sold 17,356 options to buy
@ $18.4, valued at
$319.4k
Disposed/sold 24,997 options to buy
@ $6.8, valued at
$170k
|
|
| 04/17/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/17/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/17/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/17/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/17/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/17/2019 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 04/17/2019 |
GN
| Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc |
| 04/17/2019 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 04/17/2019 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/16/2019 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/12/2019 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 04/10/2019 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/10/2019 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/27/2019 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/27/2019 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/20/2019 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 03/20/2019 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 03/15/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 03/14/2019 |
GN
| OSIRIS THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout |
| 03/12/2019 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 03/12/2019 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
| 03/12/2019 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 03/12/2019 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 03/12/2019 |
8-K
| Other Events, Financial Statements and Exhibits |
| 02/28/2019 |
GN
| Predictive Technology Group Names Jay M. Moyes to Its Board of Directors |
| 11/29/2018 |
3
| Tom Samson (President & CEO) has filed a Form 3 on OSIRIS THERAPEUTICS, INC. |
| 11/26/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/26/2018 |
GN
| Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive Officer |
| 11/08/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
|
|
|